Expanding the Degrader Toolbox for Neuro Applications

• Differentiation of TRIMTECH’s TRIM21 platform and applicability to neurodegeneration
• Data supporting selective and potent degradation of toxic protein aggregates
• Bifunctional and molecular glue strategies for these target classes

Speakers:

Nicki Thompson

Chief Executive Officer

Trimtech Therapeutics